home page

Management Team

John S. Andrews, PhD, President and Chief Scientific Officer
Tom Lategan DPhil, Vice President of Regulatory Affairs

Leadership

Management Team
Board of Directors
Board Observers
Scientific Advisory Board



John S. Andrews, PhD, President and Chief Scientific Officer

20 years experience in industrial drug discovery at Schering, Organon, Janssen and Descartes.  Various positions in pharma industry from Section Head, Project Coordinator to VP CNS Drug Discovery at Janssen Pharmaceuticals (J&J).  Former President Descartes Therapeutics.  Responsible for multiple drug projects which have entered clinical testing including several first-in-class therapies.  Projects for Organon NV and Schering AG registered; others in Phase I, II, III in depression, anxiety, schizophrenia, pain.  Continuous 25 year publication record in CNS drug discovery.  10 patents and applications in drug discovery and implementation.

Home | NeurAxon | Market | Pipeline | Research | News | Contact